Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases.
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
Sonrai Security delivers enterprise cloud security for companies running on AWS, Azure, and Google Cloud.
B12 offers website building, contact management, online scheduling, payments, invoicing, and SEO services.
AgBiome discovers and develops innovative biological and trait products for crop protection.
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Barkbox is a monthly subscription service platform that provides dog products.
Mesodyne manufactures the LightCell: a high energy density, silent, compact power generator converting any fuel to electricity via light.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Primmune Therapeutics is a Biotechnology company.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
Nomad Health is an online staffing marketplace that connects clinicians to healthcare jobs.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Proof is an identity-assured transaction management platform that verifies identities and secures digital transactions.
Sovato Health provides surgical access through remote robotic surgeon options.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Polaris Partners has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Polaris Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Software. The firm invests across 36 different industry categories.
Among tracked funding rounds, Invivyd received $125.0M in a Post Ipo Equity round. Polaris Partners's total known invested capital is $10.0B.
Polaris Partners's average investment size is $53.8M across its portfolio of 186 companies.
Recent Polaris Partners portfolio additions include 76Bio, Ankyra, Sonrai Security, B12, AgBiome. These companies were founded in 2020 or later.